Effect of hypothermia on doxorubicin-induced cardiac myoblast signaling and cell death

Cardiovascular Pathology

Volumn 21, Issue 2, 2012, Pages 96-104

  L'Ecuyer, Thomas J ^a   Aggarwal, Sanjeev ^a   Zhang, Jiang Ping ^a   Van Der Heide, Richard S ^b  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anthracyclines; Apoptosis; DNA damage pathway; Hypothermia; Mitochondrial membrane potential; Oxidative stress

Indexed keywords

DNA NUCLEOTIDYLEXOTRANSFERASE; DOXORUBICIN; HISTONE H2AX; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; DNA REPAIR; ENZYME ACTIVATION; HISTONE PHOSPHORYLATION; HYPOTHERMIA; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; MITOCHONDRIAL MEMBRANE POTENTIAL; MYOBLAST; NICK END LABELING; OXIDATIVE STRESS; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL LINE; CELL SURVIVAL; COLD TEMPERATURE; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; HYPOTHERMIA; IN SITU NICK-END LABELING; MEMBRANE POTENTIAL, MITOCHONDRIAL; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS; SIGNAL TRANSDUCTION;

EID: 84857049319     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2011.02.001     Document Type: Article

References (32)

1. MA Grenier, and SE Lipshultz Epidemiology of anthracycline cardiotoxicity in children and adults Semin Oncol 25 1998 72 85 (Pubitemid 28460388)
2. SE Lipshultz, SD Colan, RD Gelber, AR Perez-Atayde, SE Sallan, and SP Sanders Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood [see comment] N Engl J Med 324 1991 808 815
3. S Aggarwal, MD Pettersen, K Bhambhani, J Gurczynski, R Thomas, and T L'Ecuyer B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children Pediatr Blood Cancer 49 2007 812 816 (Pubitemid 47519518)
4. S Zhou, CM Palmeira, and KB Wallace Doxorubicin-induced persistent oxidative stress to cardiac myocytes Toxicol Lett 121 2001 151 157 (Pubitemid 32441771)
5. N Sarvazyan Visualization of doxorubicin-induced oxidative stress in isolated cardiac myocytes Am J Physiol 271 1996 H2079 H2085
6. HC Yen, TD Oberley, S Vichitbandha, YS Ho, and DK St. Clair The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice J Clin Invest 98 1996 1253 1260 (Pubitemid 26299939)
7. TJ L'Ecuyer, Z Allebban, R Thomas, and R Vander Heide Glutathione-S-transferase overexpression protects against anthracycline-induced H9C2 cell death Am J Physiol Heart Circ Physiol 286 2004 H2057 H2064 (Pubitemid 38685217)
8. M Lopez, P Vici, and K Di Lauro Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas J Clin Oncol 16 1998 86 92 (Pubitemid 28041583)
9. T L'Ecuyer, S Sanjeev, and R Thomas DNA damage is an early event in doxorubicin-induced cardiac myocyte death Am J Physiol Heart Circ Physiol 291 2006 H1273 H1280 (Pubitemid 44343672)
10. M Terashima, Y Ohashi, and H Azumi Impact of NAD(P)H oxidase-derived reactive oxygen species on coronary arterial remodeling: a comparative intravascular ultrasound and histochemical analysis of atherosclerotic lesions Circulation: Cardiovasc Interv 2 2009 196 204
11. N Mariappan, CM Elks, and S Sriramula NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes Cardiovasc. Res. 85 2010 473 483
12. A Kumar, SV Ramakrishna, S Basu, and GR Rao Oxidative stress in perinatal asphyxia Pediatric Neurology 38 2008 181 185 (Pubitemid 351221225)
13. S Shankaran, A Pappas, and AR Laptook Outcomes of safety and effectiveness in a multicenter randomized, controlled trial of whole-body hypothermia for neonatal hypoxic-ischemic encephalopathy Pediatrics 122 2008 e791 8
14. H Bayir, D Adelson, and S Wisniewski Therapeutic hypothermia preserves antioxidant defenses after severe traumatic brain injury in infants and children Critical Care Medicine 37 2009 689 695
15. BW Kimes, and BL Brandt Properties of a clonal muscle cell line from rat heart ExpCell Res 98 1976 367 381
16. K Itoh, Y Sasaki, and H Fujii Study of dose escalation and sequence switching of administration of the combination of docetaxel and doxorubicin in advanced breast cancer Clin Cancer Res 6 2000 4082 4090
17. C Sessa, A Perotti, and E Salvatorelli Phase IB and pharmacological study of the novel taxane BMS-184476 in combination with doxorubicin Eur J Cancer 40 2004 563 570 (Pubitemid 38220774)
18. BM Frost, S Eksborg, and O Bjork Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: multi-institutional collaborative study Med Pediatr Oncol 38 2002 329 337 (Pubitemid 34493112)
19. Q Li, R Esper, and J Loeb Synergistic effects of neuregulin and agrin on muscle acetylcholine receptor expression Mol Cell Neurosci 26 2004 558 569 (Pubitemid 38969952)
20. L Latella, J Lukas, C Simone, PL Puri, and J Bartek Differentiation- induced radioresistance in muscle cells Mol Cell Biol 24 2004 6350 6361 (Pubitemid 38891135)
21. DB Sawyer, R Fukazawa, MA Arstall, and RA Kelly Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane Circ Res 84 1999 257 265 (Pubitemid 29095566)
22. R Jeyaseelan, C Poizat, and H Wu Molecular mechanisms of doxorubicin-induced cardiomyopathy. Selective suppression of Reiske iron-sulfur protein, ADP/ATP translocase, and phosphofructokinase genes is associated with ATP depletion in rat cardiomyocytes J Biol Chem 272 1997 5828 5832 (Pubitemid 27102415)
23. 2+-ATPase gene transcription CircRes 86 2000 8 14 (Pubitemid 30044162)
24. Y Kim, AG Ma, and K Kitta Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis Mol Pharmacol 63 2003 368 377 (Pubitemid 36158372)
25. A Perez, V Suman, and N Davidson Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the north central cancer treatment group N9831 intergroup adjuvant trial J Clin Oncol 22 2004 3700 3704 (Pubitemid 41095209)
26. K Sorensen, G Levitt, C Bull, J Chessells, and I Sullivan Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity J Clin Oncol 15 1997 61 68 (Pubitemid 27020558)
27. SS Legha, RS Benjamin, and B Mackay Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion Ann Intern Med 96 1982 133 139 (Pubitemid 12172323)
28. ME O'Brien, N Wigler, and M Inbar Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer Ann Oncol 15 2004 440 449 (Pubitemid 38444547)
29. MG Paiva, AS Petrilli, VA Moises, CR Macedo, C Tanaka, and O Campos Cardioprotective effect of dexrazoxane during treatment with doxorubicin: a study using low-dose dobutamine stress echocardiography Pediatr Blood Cancer 45 2005 902 908 (Pubitemid 41552157)
30. JL Speyer, MD Green, and E Kramer Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer N Engl J Med 319 1988 745 752
31. JL Speyer, MD Green, and A Zeleniuch-Jacquotte ICRF-187 permits longer treatment with doxorubicin in women with breast cancer J Clin Oncol 10 1992 117 127
32. C Bruel, JJ Parienti, and W Marie Mild hypothermia during advanced life support: a preliminary study in out-of-hospital cardiac arrest Crit Care 12 2008 R31